SCHEMBL638075

SCHEMBL638075

CC1(C)CC(=O)CC(C)(C)C1

nearest known ligand 0.36

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.36
ALDH1A1 P00352 8/20 0.33
ALOX15 P16050 1/20 0.33
MAOA P21397 1/20 0.33
KDM4E B2RXH2 3/20 0.32
POLB P06746 1/20 0.31
LMNA P02545 1/20 0.31
CYP2C19 P33261 1/20 0.31
HTT P42858 1/20 0.30
GLA P06280 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2691041 0.86
SCHEMBL15875786 0.84 LMNA (0.34) MAPTALDH1A1ALOX15KDM4ELMNA
SCHEMBL1665247 0.81 ALDH1A1 (0.32) MAPTALDH1A1ALOX15KDM4EPOLB
SCHEMBL7752612 0.81 CES1 (0.31) MAPT
SCHEMBL12440245 0.81 MAPT (0.30) MAPT
SCHEMBL7752376 0.81 MAPT (0.30) MAPT
SCHEMBL9754962 0.80 MAPT (0.36) MAPTALDH1A1ALOX15MAOAKDM4E
SCHEMBL23183170 0.77
SCHEMBL647137 0.77 CTSK (0.36) ALDH1A1ALOX15POLB
SCHEMBL932594 0.77 KDM4E (0.46) MAPTALDH1A1ALOX15KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 633 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250194617-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-06-19 US claimed
US-20250169514-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-05-29 US claimed
US-20230380457-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-30 US claimed
EP-4280882-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2023-11-29 EP claimed
US-20230363426-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-16 US claimed
US-11793220-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2023-10-24 US claimed
US-11737481-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2023-08-29 US claimed
US-20220264914-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-08-25 US claimed
WO-2022159439-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2022-07-28 WO claimed
US-20220225647-A1 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. 2022-07-21 US claimed
WO-2011000537-A1 METHOD OF PREPARING 1-CHLOROACETAMIDO-1,3,3,5,5-PENTAMETHYLCYCLOHEXANE MERZ PHARMA GMBH & CO. KGAA (DE) 2011-01-06 WO claimed
WO-2011000538-A1 METHOD OF PREPARING NERAMEXANE MERZ PHARMA GMBH & CO. KGAA (DE) 2011-01-06 WO claimed
WO-2011000540-A1 METHOD OF PREPARING 3,3,5,5-TETRAMETHYLCYCLOHEXANONE MERZ PHARMA GMBH & CO. KGAA (DE) 2011-01-06 WO claimed
WO-2011000536-A1 METHOD OF PREPARING 1-HYDROXY-1,3,3,5,5-PENTAMETHYLCYCLOHEXANE MERZ PHARMA GMBH & CO. KGAA (DE) 2011-01-06 WO claimed
WO-2011000539-A1 METHOD OF PREPARING NERAMEXANE MERZ PHARMA GMBH & CO. KGAA (DE) 2011-01-06 WO claimed
WO-2010118889-A1 SYNTHESIS OF 1-AMINO-1,3,3,5,5-PENTAMETHYLCYCLOHEXANE MESYLATE MERZ PHARMA GMBH & CO. KGAA (DE) 2010-10-21 WO claimed
US-20060167281-A1 1,2,4- Trioxepanes as precursors for lactones AKZO NOBEL N.V. (NL) 2006-07-27 US claimed
EP-1646618-A1 1,2,4,-TRIOXEPANES AS PRECURSORS FOR LACTONES Akzo Nobel N.V. (NL) 2006-04-19 EP claimed
WO-2005014569-A1 1,2,4,-TRIOXEPANES AS PRECURSORS FOR LACTONES AKZO NOBEL N.V. (NL) 2005-02-17 WO claimed
US-4493904-A COORDINATION, POLYMERIZATION CATALYST CONTAINING TITANIUM TRICHORI CONOCO INC. (US) 1985-01-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167281-A1 1,2,4- Trioxepanes as precursors for lactones CYP4X1, LSS, RIOX2 MAPT 4784/4885ALDH1A1 3302/4885ALOX15 684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.